6533b833fe1ef96bd129b755
RESEARCH PRODUCT
DNA-binding activities of compounds acting as enzyme inhibitors, ion channel blockers and receptor binders.
Nikolajs SjaksteLada ŽIvkovićMaija DzintareRuslans Muhamadejevssubject
Drugmedia_common.quotation_subjectmedicine.medical_treatmentToxicologyGenomeIon ChannelsArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineAnimalsHumansEnzyme InhibitorsReceptorIon channel030304 developmental biologymedia_commonchemistry.chemical_classification0303 health sciencesProteaseGeneral MedicineDNA3. Good healthEnzymeMechanism of actionchemistryBiochemistry030220 oncology & carcinogenesismedicine.symptomDNAdescription
The DNA-binding activities of compounds used as remedies can display DNA-protection, but also damaging effects in biological systems. The current review compiles literature data on DNA-binding activities of drugs widely used as remedies with different therapeutic indications. The compounds are classified according their mechanism of action: enzyme inhibitors, ion channel inhibitors, inhibitors of viral RNA replication and HIV protease and receptor agonists. DNA binding was reported for such widely used drugs as paracetamol, aspirin, metformin, statins and many others. The capability of the drug to bind DNA is sometimes coupled to genotoxic effects, but in some cases - to genome protection. Data on atoms and chemical groups involved in the drug-DNA interactions are also presented. In many cases the same atoms are involved in both interactions of the compounds with proteins and DNA.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-10-01 | Chemico-biological interactions |